Abstract
Aramark will report fiscal second-quarter results on May 12, 2026 Pre-Market, with consensus pointing to mid-single-digit organic growth layered with currency tailwinds, stable margins, and potential modest upside if new-contract ramp and education mix prove supportive.Market Forecast
Consensus points to revenue of 4.75 billion US dollars for the quarter, up 9.20% year over year, adjusted EPS around $0.47, up 44.83% year over year, and EBIT near 251.21 million US dollars, up 23.43% year over year; current commentary suggests broadly stable gross and net margins absent formal company margin guidance. Main operations are expected to benefit from resilient base volumes, record retention, and net new wins, with the education calendar mix and steady business-and-industry demand supporting both growth and quality of revenues. The most promising near-term pipeline appears concentrated in business-and-industry accounts, including datacenter-related contracts that could scale over a multi-year horizon, though separate revenue and year-over-year breakouts for this sub-vertical are not disclosed.Last Quarter Review
In the prior quarter, Aramark reported revenue of 4.83 billion US dollars, a gross profit margin of 8.61%, GAAP net profit attributable to shareholders of 96.16 million US dollars, a net profit margin of 1.99%, and adjusted EPS of $0.51, flat year over year. Net profit increased 10.35% quarter on quarter, supported by operating leverage and a healthy contribution from base business volume and new wins. The core Food and Support Services business delivered 4.83 billion US dollars of revenue in the quarter, with total-company revenue up 6.14% year over year, reflecting sustained client retention and the early impact of newly awarded contracts.Current Quarter Outlook
Main Business Outlook
The quarter should reflect the continued ramp of recently awarded contracts combined with resilient base volumes, which together support revenue growth and operating efficiency. Retention rates have been exceptionally strong across the book of business, limiting churn and preserving a foundation for organic expansion; this backdrop enables pricing and mix actions to flow more fully to earnings. Education remains a mix driver this quarter, as the academic calendar shapes volumes and typically supports throughput and productivity in dining operations. Taken together, consensus revenue growth of roughly 9.20% year over year and a 23.43% lift in EBIT imply incremental margin progress on a normalized basis, with most sell-side commentary framing margins as stable to modestly higher. Sequential comparisons for EPS may be mixed due to calendar factors, yet year-over-year growth is projected to be robust given a cleaner expense base relative to last year’s setup.Largest Growth Opportunity
The most substantial multi-year opportunity sits within business-and-industry accounts, where large-scale, multi-site relationships and datacenter-related contracts tied to hyperscaler buildouts offer a visible runway. Sell-side previews emphasize this pipeline as a differentiator, with early-stage deployments creating a second-half ramp that should contribute increasingly to revenue density and margin efficiency over time. While management has not provided a discrete revenue or margin guide by sub-vertical, new-business activation timelines and client ramp profiles tend to bunch across several quarters, which can create a cumulative uplift on both volumes and productivity metrics. Healthcare wins also add depth to the opportunity set, with notable contract commencements from recent quarters set to contribute progressively as teams and supply programs achieve scale. The near-term read-through is that stronger net new business, layered on high retention, can sustain organic growth above what some models assume for out years, especially if ramp costs are contained and productivity initiatives hold.Key Stock Price Drivers This Quarter
Two earnings variables are likely to matter most for the stock: the revenue print versus consensus and the direction of margins on a sequential and year-over-year basis. On the top line, investors will look for confirmation of steady base volumes and tangible contribution from new wins; a beat on revenue, even modest, would reinforce the message embedded in the full-year outlook. On margins, commentary from analysts anticipates stability backed by favorable education mix, operating discipline, and procurement benefits; confirmation of this dynamic would help the multiple if EPS tracks or exceeds $0.47. Management’s stance on the full-year revenue framework (19.55–19.95 billion US dollars, reiterated previously) will also be a catalyst, as any nudge toward the midpoint or above would validate positive quarterly trends implied by the forecasts. Foreign-exchange effects are likely to be a slight tailwind, and any updates to the cadence of contract ramp—particularly in business-and-industry and healthcare—could influence revisions to second-half expectations. Finally, color on start-up costs, pricing, and client mix will shape how investors extrapolate the projected EBIT growth of 23.43% year over year into subsequent quarters.Analyst Opinions
Based on recent commentary, the ratio of bullish to bearish views is approximately 5:0, with several Buy recommendations and one neutral stance reinforcing a constructive near-term setup. UBS Securities reiterated a positive view and maintained a Buy rating, highlighting an expected “constructive” fiscal second quarter underpinned by steady demand, improving margins, and education mix support; UBS sees quarterly revenue growth of about 11.5% driven by roughly 10.1% organic growth plus a 1.4% currency tailwind, and it maintained a price target near $48, underscoring confidence in the full-year framework. Oppenheimer described expectations for a “clean” fiscal second quarter, citing solid performance across business-and-industry, education, and healthcare, and posited that execution across these verticals can maintain the growth cadence investors have been modeling for the spring period.Truist Securities maintained a Buy rating and lifted its target price to $50, noting that the company’s retention and net new wins continue to exceed historical norms and that the bookings pipeline has remained favorable; the firm framed the quarter as a test of the new-business ramp’s velocity and its translation into revenue quality. Bank of America Securities reiterated a Buy rating with a price target of $52, pointing to multi-quarter visibility from recent mega-contracts, a supportive demand backdrop, and potential upside to consensus if operating income converts as modeled; the analyst credited the setup for enabling modest margin expansion despite the calendar. Morgan Stanley kept an Equal-Weight rating with a $45 target but acknowledged that organic revenue trends and record retention create a constructive platform for meeting full-year goals; in their view, the quarter hinges on margin execution and the cadence of new-contract activation, both of which are tracking acceptably.
In aggregate, the prevailing analyst stance is that Aramark enters the print with a balanced and favorable operating profile—resilient base business, high retention, and visible net new wins—supported by incremental FX tailwinds and a beneficial education mix. The majority expects a confirmation of full-year guidance alongside a revenue and EBIT performance that is at or a touch above consensus, with adjusted EPS near $0.47. Where opinions converge is on the multi-year potential of business-and-industry accounts, including datacenter-related contracts tied to hyperscaler builds; analysts view these as catalysts that can sustain above-trend organic growth if start-up expenses moderate as expected. The bullish case emphasizes that consistent contract wins, improving productivity, and disciplined cost control can keep margins stable to slightly higher even as the mix evolves, thereby reinforcing the earnings growth trajectory implied by the quarter’s forecasts. As a result, the majority view anticipates a supportive reaction if management confirms steady execution and reiterates the full-year revenue range of 19.55–19.95 billion US dollars with unchanged or improved confidence in conversion to operating income.